Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Coutant

Showing results (71-80 of 189) with videos related to

Pageof 19
Sort By:
Gynecologic Oncology|October 30, 2016
Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study GroupSofiane Bendifallah, Lobna Ouldamer, Vincent Lavoue, et al.
Annals of Surgical Oncology|December 16, 2014
Severe Obesity Impacts Recurrence-Free Survival of Women with High-Risk Endometrial Cancer: Results of a French Multicenter StudyGeoffroy Canlorbe, Sofiane Bendifallah, Emilie Raimond, et al.
American Journal of Obstetrics and Gynecology|July 2, 2014
External validation of nomograms designed to predict lymphatic dissemination in patients with early-stage endometrioid endometrial cancer: a multicenter studySofiane Bendifallah, Geoffroy Canlorbe, Emilie Raimond, et al.
Bulletin Du Cancer|November 9, 2019
[Strategies in case of metastatic sentinel lymph node in breast cancer]Hélène Costaz, Magali Rouffiac, Delphine Boulle, et al.
Breast Cancer (Tokyo, Japan)|January 30, 2023
HER2-positive invasive lobular carcinoma: a rare breast cancer which may not necessarily require anti-HER2 therapy. A population-based studySamia Kada Mohammed, Oumar Billa, Sylvain Ladoire, et al.
British Journal of Cancer|July 18, 2020
Survival in patients with HR+/HER2- metastatic breast cancer treated with initial endocrine therapy versus initial chemotherapy. A French population-based studyJulien Simon, Marie Chaix, Oumar Billa, et al.
Maturitas|April 26, 2015
Impact of age-related socio-economic and clinical determinants of quality of life among long-term breast cancer survivorsPegdwende Olivia Dialla, Wai-On Chu, Patrick Roignot, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 26, 2016
Determinants of quality of life among long-term breast cancer survivorsWai-On Chu, Pegdwende Olivia Dialla, Patrick Roignot, et al.
Cancer Reports (Hoboken, N.J.)|April 19, 2023
Impact of therapeutic strategy on disease-free and overall survival of early-stage cervical cancer: Surgery alone versus preoperative radiationKatia Mahiou, Laura Vincent, Karine Peignaux-Casasnovas, et al.
Annals of Surgical Oncology|June 28, 2014
A risk scoring system to determine recurrence in early-stage type 1 endometrial cancer: a French multicentre studySofiane Bendifallah, Geoffroy Canlorbe, Florence Huguet, et al.
Pageof 19

Showing results (71-80 of 189) with videos related to

Sort By:
Pageof 19
Gynecologic Oncology|October 30, 2016
Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study GroupSofiane Bendifallah, Lobna Ouldamer, Vincent Lavoue, et al.
Annals of Surgical Oncology|December 16, 2014
Severe Obesity Impacts Recurrence-Free Survival of Women with High-Risk Endometrial Cancer: Results of a French Multicenter StudyGeoffroy Canlorbe, Sofiane Bendifallah, Emilie Raimond, et al.
American Journal of Obstetrics and Gynecology|July 2, 2014
External validation of nomograms designed to predict lymphatic dissemination in patients with early-stage endometrioid endometrial cancer: a multicenter studySofiane Bendifallah, Geoffroy Canlorbe, Emilie Raimond, et al.
Bulletin Du Cancer|November 9, 2019
[Strategies in case of metastatic sentinel lymph node in breast cancer]Hélène Costaz, Magali Rouffiac, Delphine Boulle, et al.
Breast Cancer (Tokyo, Japan)|January 30, 2023
HER2-positive invasive lobular carcinoma: a rare breast cancer which may not necessarily require anti-HER2 therapy. A population-based studySamia Kada Mohammed, Oumar Billa, Sylvain Ladoire, et al.
British Journal of Cancer|July 18, 2020
Survival in patients with HR+/HER2- metastatic breast cancer treated with initial endocrine therapy versus initial chemotherapy. A French population-based studyJulien Simon, Marie Chaix, Oumar Billa, et al.
Maturitas|April 26, 2015
Impact of age-related socio-economic and clinical determinants of quality of life among long-term breast cancer survivorsPegdwende Olivia Dialla, Wai-On Chu, Patrick Roignot, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 26, 2016
Determinants of quality of life among long-term breast cancer survivorsWai-On Chu, Pegdwende Olivia Dialla, Patrick Roignot, et al.
Cancer Reports (Hoboken, N.J.)|April 19, 2023
Impact of therapeutic strategy on disease-free and overall survival of early-stage cervical cancer: Surgery alone versus preoperative radiationKatia Mahiou, Laura Vincent, Karine Peignaux-Casasnovas, et al.
Annals of Surgical Oncology|June 28, 2014
A risk scoring system to determine recurrence in early-stage type 1 endometrial cancer: a French multicentre studySofiane Bendifallah, Geoffroy Canlorbe, Florence Huguet, et al.
Pageof 19